Improving the Quality of Cancer Clinical Trials: Workshop Summary

✍ Scribed by Margie Patlak, Sharyl Nass

Publisher: National Academies Press
Year: 2008
Tongue: English
Leaves: 137
Edition: 1
Category: Library

No coin nor oath required. For personal study only.

✦ Synopsis

Scientists and clinicians seek a new paradigm that could improve the efficiency, cost-effectiveness, and overall success rate of cancer clinical trials, while maintaining the highest standards of quality. To explore innovative paradigms for cancer clinical trials and other ways to improve their quality, the National Cancer Policy Forum held a workshop, Improving the Quality of Cancer Clinical Trials, in Washington, DC. The main goals of the workshop were to examine new approaches to clinical trial design and execution that would: better inform decisions and plans of those responsible for developing new cancer therapies; more rapidly move new diagnostic tests and treatments toward regulatory approval and use in the clinic; and, be less costly than current trials. The resulting workshop summary will serve as input to the deliberations of an Institute of Medicine committee that will develop consensus-based recommendations for moving the field of cancer clinical trials forward.

📜 SIMILAR VOLUMES

Implementing a National Cancer Clinical

📁 Implementing a National Cancer Clinical Trials System for the 21st Century: A Workshop Summary

✍ National Cancer Policy Forum, Institute of Medicine, American Society of Clinica 📂 Library 📅 2011 🏛 National Academies Press 🌐 English

Clinical trials enable scientific discoveries to advance patient care, in addition to informing and guiding subsequent research. The National Cancer Institute's (NCI's) Clinical Trials Cooperative Group Program works to advance patient care and research. The Cooperative Group Program has been instru

Assessing and Improving Value in Cancer

📁 Assessing and Improving Value in Cancer Care: Workshop Summary

✍ Institute of Medicine 📂 Library 📅 2009 🏛 National Academies Press 🌐 English

Unlike many other areas in health care, the practice of oncology presents unique challenges that make assessing and improving value especially complex. First, patients and professionals feel a well-justified sense of urgency to treat for cure, and if cure is not possible, to extend life and reduce t

Implementing a national cancer clinical

📁 Implementing a national cancer clinical trials system for the 21st century : second workshop summary : an American Society of Clinical Oncology and Institute of Medicine Workshop

✍ Nass, Sharyl J.; Patlak, Margie 📂 Library 📅 2013 🏛 National Academies Press 🌐 English

"The National Clinical Trials Network (NCTN) supported by the National Cancer Institute (NCI) has played an integral role in cancer research and in establishing the standard of care for cancer patients for more than 50 years. Formerly known as the NCI Clinical Trials Cooperative Group Program, the N

Improving Quality of Care in Low- and Mi

📁 Improving Quality of Care in Low- and Middle-Income Countries: Workshop Summary

✍ and Medicine Engineering National Academies of Sciences; Institute of Medicine; 📂 Library 📅 2015 🏛 National Academies Press 🌐 English

Quality of care is a priority for U.S. Agency for International Development (USAID). The agency's missions abroad and their host country partners work in quality improvement, but a lack of evidence about the best ways to facilitate such improvements has constrained their informed selection of interv

CNS Clinical Trials: Suicidality and Dat

📁 CNS Clinical Trials: Suicidality and Data Collection: Workshop Summary

✍ Forum on Neuroscience and Nervous System Disorders 📂 Library 📅 2010 🏛 National Academies Press 🌐 English

The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervou

Cancer Clinical Trials: A Critical Appra

📁 Cancer Clinical Trials: A Critical Appraisal

✍ U. Tröhler (auth.), Dr. Hans Scheurlen, Dr. Richard Kay, Professor Dr. Michael B 📂 Library 📅 1988 🏛 Springer-Verlag Berlin Heidelberg 🌐 English

<p>The controlled clinical trial has become an essential part of the clinician's decision-making process. Clinical trials, however, still raise methodological problems that are important and at the same time controversial: subgroup analysis and interactions, meta-analy sis of similar trials, consid